- Home
- PWM vs PYPD Comparison
PWM vs PYPD Comparison
Compare PWM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- PYPD
- Stock Information
- Founded
- PWM 2018
- PYPD 2008
- Country
- PWM Hong Kong
- PYPD Israel
- Employees
- PWM N/A
- PYPD N/A
- Industry
- PWM
- PYPD Medical/Dental Instruments
- Sector
- PWM
- PYPD Health Care
- Exchange
- PWM Nasdaq
- PYPD Nasdaq
- Market Cap
- PWM 34.6M
- PYPD 29.1M
- IPO Year
- PWM 2023
- PYPD 2020
- Fundamental
- Price
- PWM $1.33
- PYPD $3.10
- Analyst Decision
- PWM
- PYPD Strong Buy
- Analyst Count
- PWM 0
- PYPD 2
- Target Price
- PWM N/A
- PYPD $10.50
- AVG Volume (30 Days)
- PWM 939.3K
- PYPD 26.8K
- Earning Date
- PWM 02-14-2025
- PYPD 02-12-2025
- Dividend Yield
- PWM N/A
- PYPD N/A
- EPS Growth
- PWM N/A
- PYPD N/A
- EPS
- PWM N/A
- PYPD N/A
- Revenue
- PWM $348,528.00
- PYPD N/A
- Revenue This Year
- PWM N/A
- PYPD N/A
- Revenue Next Year
- PWM N/A
- PYPD N/A
- P/E Ratio
- PWM N/A
- PYPD N/A
- Revenue Growth
- PWM N/A
- PYPD N/A
- 52 Week Low
- PWM $0.67
- PYPD $2.37
- 52 Week High
- PWM $2.70
- PYPD $7.00
- Technical
- Relative Strength Index (RSI)
- PWM 51.87
- PYPD 44.51
- Support Level
- PWM $1.02
- PYPD $2.88
- Resistance Level
- PWM $2.70
- PYPD $3.48
- Average True Range (ATR)
- PWM 0.36
- PYPD 0.28
- MACD
- PWM -0.02
- PYPD -0.02
- Stochastic Oscillator
- PWM 29.38
- PYPD 19.58
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.